一个患有口腔炎和腹的孩子.
Gianluca Terrin1, Osvaldo Borrelli, Giovanni Di Nardo
1Pediatric Gastroenterology Unit, University of Rome La Sapienza, 00161 Rome, Italy.
Lancet (London, England)
|February 7, 2002
概括
No abstract available in PubMed .
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
662
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
662
Probability Laws
44.0K
Overview
44.0K
Punnett Squares
125.3K
Overview
125.3K
Pedigree Analysis
89.0K
Overview
89.0K


